Three-Dimensional 3D Culture Models in Gynecological and Breast Cancer Research

Bibliographic Details
Title: Three-Dimensional 3D Culture Models in Gynecological and Breast Cancer Research
Authors: Yarely M. Salinas-Vera, Jesús Valdés, Yussel Pérez-Navarro, Gilberto Mandujano-Lazaro, Laurence A. Marchat, Rosalio Ramos-Payán, Stephanie I. Nuñez-Olvera, Carlos Pérez-Plascencia, César López-Camarillo
Source: Frontiers in Oncology, Vol 12 (2022)
Publisher Information: Frontiers Media S.A., 2022.
Publication Year: 2022
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: 3D cultures, breast cancer, gynecological cancers, microRNAs, therapy response, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Traditional two-dimensional (2D) monolayer cell cultures have long been the gold standard for cancer biology research. However, their ability to accurately reflect the molecular mechanisms of tumors occurring in vivo is limited. Recent development of three-dimensional (3D) cell culture models facilitate the possibility to better recapitulate several of the biological and molecular characteristics of tumors in vivo, such as cancer cells heterogeneity, cell-extracellular matrix interactions, development of a hypoxic microenvironment, signaling pathway activities depending on contacts with extracellular matrix, differential growth kinetics, more accurate drugs response, and specific gene expression and epigenetic patterns. In this review, we discuss the utilization of different types of 3D culture models including spheroids, organotypic models and patient-derived organoids in gynecologic cancers research, as well as its potential applications in oncological research mainly for screening drugs with major physiological and clinical relevance. Moreover, microRNAs regulation of cancer hallmarks in 3D cell cultures from different types of cancers is discussed.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2234-943X
Relation: https://www.frontiersin.org/articles/10.3389/fonc.2022.826113/full; https://doaj.org/toc/2234-943X
DOI: 10.3389/fonc.2022.826113
Access URL: https://doaj.org/article/5e3daf97fa97428ba88cc44fbe1d4b44
Accession Number: edsdoj.5e3daf97fa97428ba88cc44fbe1d4b44
Database: Directory of Open Access Journals
More Details
ISSN:2234943X
DOI:10.3389/fonc.2022.826113
Published in:Frontiers in Oncology
Language:English